Catalyst Wire Dossier Catalyst Wire Dossier

recombinant von Willebrand factor

recombinant von Willebrand factor · Takeda
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for recombinant von Willebrand factor, covering 2016-04-21 to 2026-03-11. Get the full timeline:

Most recent: Clinical Trial Update: A Study on the Outcomes of Recombinant Von Willebrand Factor on Demand Treatment and Prevention and Treatment of Bleeding During and After Surgery in Adults With Inherited Von Willebrand Disease in the United Kingdom (UK)

See pricing